Ironwood Pharmaceuticals appoints new CEO
- Tammi Gaskins appointed CEO effective Jan 1, 2027
- Thomas McCourt retires as CEO Dec 31, 2026 after 17 years
- Gaskins to receive $775,000 annual salary and $2M in stock units
Every EDGAR filing for IRONWOOD PHARMACEUTICALS INC (IRWD), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 9 ยท 10-Q expected ~Nov 9 (deadline Nov 9)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Michael Shetzline, planned sale of IRWD shares
Michael Shetzline, reporting
Alexander J Denner, insider filing for IRWD
Alexander J Denner, reporting
Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)
ARMISTICE CAPITAL, LLC, filed by
Ownership stake disclosure by STATE STREET CORP
STATE STREET CORP, filed by
Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
Jeffrey Silber, insider filing for IRWD
Jeffrey Silber, reporting
Ronald Silver, insider filing for IRWD
Ronald Silver, reporting
Ronald Silver, planned sale of IRWD shares
Ronald Silver, reporting
Jay Shepard, insider filing for IRWD
Jay Shepard, reporting
Julie McHugh, planned sale of IRWD shares
Julie McHugh, reporting
Ronald Silver, insider filing for IRWD
Ronald Silver, reporting
Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)
ARMISTICE CAPITAL, LLC, filed by
Ownership stake disclosure by RENAISSANCE TECHNOLOGIES LLC (amended)
RENAISSANCE TECHNOLOGIES LLC, filed by
Ownership stake disclosure by BANK OF AMERICA CORP /DE/ (amended)
BANK OF AMERICA CORP /DE/, filed by
Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
Ownership stake disclosure by Sarissa Capital Management LP (amended)
Sarissa Capital Management LP, filed by
Alexander J Denner, insider filing for IRWD
Alexander J Denner, reporting
Thomas A MCCOURT, insider filing for IRWD
Thomas A Mccourt, reporting
Gregory S. Martini, insider filing for IRWD
Gregory S. Martini, reporting